Causes and effects of the chronic inflammation in venous leg ulcers.
The pathogenesis of venous leg ulcers is multifactorial. In this review article new physiological, molecular and cellular abnormalities in venous ulcers related to the chronic inflammation are presented and discussed. Venous hypertension causes disturbed microcirculation and pathological changes of the capillaries, which eventually locks the condition in a self-amplifying, detrimental cascade with persistent elevated levels and activities of pro-inflammatory cytokines and proteases preventing progress into a healing phase. As a consequence fibroblasts senescence and become less responsive to growth factors the older the ulcers become. Current data imply there is no deficiency but rather an unfavorable distribution of growth factors in venous ulcers. An imbalance in proteolytic enzymes and their endogenous inhibitors is a common finding in chronic venous leg ulcers. Variation in disease severity and concomitant ailments in this heterogeneous patient group may explain the contradictory results in the literature. Thus, to advance the areas of research further, longitudinal studies involving larger number of patients are required to identify the major pathogenic factors.
Agren
M S
MS
Copenhagen Wound Healing Center, Bispebjerg Hospital, University of Copenhagen, Denmark. svenper@hotmail.com
Eaglstein
W H
WH
Ferguson
M W
MW
Harding
K G
KG
Moore
K
K
Saarialho-Kere
U K
UK
Schultz
G S
GS
D002908:Chronic Disease; D016207:Cytokines / Q000378:metabolism; D010450:Endopeptidases / Q000378:metabolism; D005347:Fibroblasts / Q000473:pathology; D006133:Growth Substances / Q000378:metabolism; D006801:Humans; D007249:Inflammation; D007866:Leg / Q000098:blood supply; D008137:Longitudinal Studies; D011480:Protease Inhibitors / Q000378:metabolism; D014647:Varicose Ulcer / Q000209:etiology* / Q000503:physiopathology*; D014689:Venous Insufficiency / Q000209:etiology / Q000503:physiopathology
D016207:Cytokines; D006133:Growth Substances; D011480:Protease Inhibitors; D010450:Endopeptidases